MedTrace Logo

"Hjerteloeftet" ("HeartLift"). Interaction For Preventing Cardiovascular Disease

NCT01741428 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 701

Last updated 2020-02-28

No results posted yet for this study

Summary

Early interventions to promote physical activity, dietary lifestyle changes and optimal medication for cardiovascular risk factor reduction - 3 years follow-up. A randomized Clinical Trial.

Conditions

Interventions

BEHAVIORAL

Intervention (INT1)

The course Program at the Feiring Heart Clinic will: Clinical examination and ergospirometric testing, optimizing both treatment and prophylactic medication. Promoting physical Activity, changes in lifestyle, dietary changes/weight reduction, smoking cessation. In the follow-up period the participants will be contacted and report regularly through a web-based secure program (MedAxess)(such as: Activity-, dietary- and smoking habits). Each participant will have their own Mentor, helping keeping up the motivation. They will also meet regularly at the local doctors Office which reports relevant parameters to the Project (such as weight, BP, Lipoproteins, blood glucose/HbA1C)

Sponsors & Collaborators

  • LHL Helse

    lead OTHER

Principal Investigators

  • Hilde Bergum, MD · LHL Hospital Gardermoen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2019-02-06
Completion
2019-02-06

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741428 on ClinicalTrials.gov